Advanced Lung Cancer Immunotherapy Can Stop After Two Years
Non-small cell lung cancer (NSCLC) survival benefits don’t extend with further immunotherapy treatment. Limiting treatment can also improve quality of life.
Source: everydayhealth.com
Stay updated with breaking news from Outcomes Are. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Non-small cell lung cancer (NSCLC) survival benefits don’t extend with further immunotherapy treatment. Limiting treatment can also improve quality of life.
Meeting news dominated our top 10 this month, but a feature story on new weight-loss drugs also made the list.